The aging modulator miR-29 is essential for adult cardiomyocyte function
Authors:
- David Roiz-ValleDRDavid Roiz-Valle
- Cintia FolgueiraCFCintia Folgueira
- Lucas Moledo-NodarLMLucas Moledo-Nodar
- Antonio G. TartiereATAntonio G. Tartiere
- Beatriz CicuéndezBCBeatriz Cicuéndez
- Rafael Romero-BecerraRRRafael Romero-Becerra
- You-Wen HeYHYou-Wen He
- José M.P. FreijeJFJosé M.P. Freije
- Guadalupe SabioGSGuadalupe Sabio
- Carlos López-OtínCLCarlos López-Otín
- Xurde M. CaraviaXCXurde M. Caravia
Preprint
Abstract
Aging is the main risk factor for cardiovascular diseases, underscoring the need to identify the molecular regulators that sustain cardiac function during aging. The microRNA miR-29 is a well-established aging-associated regulator as its expression increases with age, and its overexpression promotes premature aging. Here, we define the cardiomyocyte-autonomous role of miR-29 in the adult heart by generating an inducible, cardiomyocyte-specific miR-29-deficient mouse model (Heart-iKO). We show that Heart-iKO mice develop dilated cardiomyopathy (DCM) with reduced ejection fraction that ultimately leads to premature death. Mechanistically, Heart-iKO cardiomyocytes exhibit alterations in mitochondrial structure and function. Transcriptomic profiling of bulk heart tissue and isolated cardiomyocytes revealed a consistent downregulation of genes involved in oxidative phosphorylation and the electron transport chain. We further observed a similar pattern of mitochondrial impairment in miR-29-deficient human cardiomyocytes derived from induced pluripotent stem cells (CM-iPSCs). Together, these findings highlight the context-dependent role of miR-29 in cardiac physiology and aging: although its upregulation promotes premature aging, its basal expression is required to maintain mitochondrial homeostasis and prevent heart failure in the adult myocardium.Keywords
Funding Information
- Consejería de Ciencia, Innovación y Universidad, Asturias, ES (IDE/2024/000784)
- La Caixa Foundation (LCF/BQ/DR21/11880010)
- La Caixa Foundation (HR24-00581)
- European Research Council (ERC Synergy AdipoHealth)
- Comunidad de Madrid (Syg-2024/Salgl-1012, AdipohearTCM)
- Cris contra el Cancer (PR_EX_2024-22)
This publication has 39 references indexed in Scilit:
- From geroscience to precision geromedicine: Understanding and managing agingCell, 2025
- Tidyplots empowers life scientists with easy code‐based data visualizationiMeta, 2025
- miRNAs to the rescue: Reversing heart failure by targeting miR-29Molecular Therapy Nucleic Acids, 2023
- Modulation of miR-29 influences myocardial compliance likely through coordinated regulation of calcium handling and extracellular matrixMolecular Therapy Nucleic Acids, 2023
- Instance segmentation of mitochondria in electron microscopy images with a generalist deep learning model trained on a diverse datasetCell Systems, 2023
- Hallmarks of aging: An expanding universeCell, 2023
- Metabolic Maturation Media Improve Physiological Function of Human iPSC-Derived CardiomyocytesCell Reports, 2020
- A Systematic Review of miR-29 in CancerMolecular Therapy-Oncolytics, 2019
- Geroscience: Linking Aging to Chronic DiseaseCell, 2014
- Modeling Survival Data: Extending the Cox Model2000